This study states that Hybrid endovascular plus open management of aortoiliac occlusive disease (AIOD) has been adopted to avoid the morbidity associated with aortobifemoral (ABF) bypass. Such a hybrid treatment of AIOD, termed EndoABF bypass, entails aortic and iliac stenting with or without femoral endarterectomy. The objective of this study was to compare outcomes of ABF and EndoABF bypasses in patients with comparable TransAtlantic Inter-Society Consensus (TASC) D lesions. This is a single-center, retrospective review of patients treated with ABF or EndoABF bypass for comparable TASC D lesions between 2010 and 2018. ABF bypass patients were included only if they were deemed anatomic candidates also for EndoABF bypass after review of preoperative imaging. Patients with acute limb ischemia were excluded. Statistics included Fisher exact testing, Kaplan-Meier analysis, and Cox proportional hazards regression.
There were 56 ABF bypasses and 1020 cases of aortic or iliac stenting performed during the study period. Of these, we identified 24 ABF bypasses and 75 EndoABF bypasses meeting inclusion criteria. The primary indication for treatment was claudication in 55 (55.6%) patients, rest pain in 28 (28.3%), and tissue loss in 16 (16.2%). Patients undergoing EndoABF bypass were more likely to be female.
Reference link-https://www.jvascsurg.org/article/S0741-5214(20)31990-X/fulltext
